Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring

Exclusion Criteria

• •1. Kidney donor is an identical twin of the subject.
• •2. The subject has another previously transplanted organ in situ.
• •3. Subject has received a hematopoietic stem cell transplant.
• •4. Subject has received a bone marrow graft.
• •5. Subject has self-reported as pregnant.
• •6. In the opinion of the investigator, the subject's participation in the study would pose a risk to data integrity or to the subject's safety and welfare.
• •1. Sample collected from someone that had an invasive graft biopsy ≤ 48 hours prior to blood draw.
• •2. Sample collected from subject that received immunosuppressive treatment for biopsy-proven acute rejection ≤ 30 days prior to blood draw
• •3. Sample collected from subject that received a blood transfusion ≤ 30 days prior to blood draw.
• •4. Sample collected from a subject that provided another sample for the study within the past 7 days.